We are thrilled to present the 9th annual conference on
Biosimilars & Biobetters, taking place on 26th & 27th September in Central London, UK.
Following the success of our previous events in both UK and USA,
Biosimilars and Biobetters UK 2018 will deliver a stellar speaker line-up and bring together a global audience of
biosimilar experts to discuss the latest developments and future of the rapidly evolving and expanding
biosimilars market.
After over a decade, the biosimilars industry is finally reaching a stage where key stakeholders understand and accept
biosimilars. This is reflected in more tolerant legislation and an increased uptake of
biosimilars across the globe.
We are now entering a very exciting time, for over the next few years several originator patents are expiring, and we will see a new wave of biosimilars enter the market. Will the originator dominate or will the biosimilar be a successful contender and spark a competitive environment? Have we done enough to convince the payer, prescriber and patient to switch?
Who should attend
Job Titles & Departments
Chief Executives, Vice Presidents, Executive Directors, Directors, Heads, Managers and Specialists from the following, but not limited to, sectors should attend:
- Biosimilars / Biologics
- Biopharmaceuticals
- Research and Development
- Legal Affairs
- Intellectual Property
- Regulatory Compliance
- Quality affairs and control
- Pharmacovigilance, Drug Safety and Risk Management
- Business Development
- Commercialisation
- Marketing and sales
Plus Two Interactive Half-Day Pre-Conference Workshops | Tuesday 25th September 2018
Workshop A: Global Development of Biosimilars: A RefresherWorkshop Leader: Michel Mikhail, Global Expert in Biosimilars
08.30 - 12.30
Workshop B: Value Based Agreements with Biosimilars: Architecture of Value Based AgreementsWorkshop Leader: Omar Ali, Visiting Lecturer Value Based Pricing, University of Portsmouth & Former Adviser, NICE
13.30 - 17.30
Speakers
- Aurelio Arias, Senior Thought Leadership Consultant, Iqvia
- Christian Naumann, Head Global Marketing Biopharmaceuticals, Sandoz International GmBH
- Daotian Fu, General Manager, Livzon Mabpharm
- Divya Chadha Manek, Head of Business Development Commercial, National Institute for Health Research
- Ekkehard Brockstedt, Team Leader Outsourced Trials, Boehringer Ingelheim
- Fraser Cummings, Consultant Gastroenterologist and Hon. Associate Professor, University Hospital Southampton NHS Foundation Trust
- Meenu Wadhwa, Head, Cytokines & Growth Factors, Biotherapeutics Group, , National Institute for Biological Standards and Control
- Michael Muenzberg, Member of the Comparative Outcomes Group , Former Medical Director Biosimilars EU, Amgen
- Michel Mikhail, International Expert in Regulatory Affairs, Independant Consultant
- Mourad Farouk Rezk, Global Head Medical Affairs Biosimilars, Biogen
- Niklas Czeloth, Project Manager DMPK Biosimilars, Boehringer Ingelheim GmbH
- Omar Ali, Visiting Lecturer, Value Based Pricing & Outcomes Based Innovative Contracting and Former Advisor to NICE, University Of Portsmouth
- Paul Harmon, Senior Director, European Oncology Biologics Lead, Mylan Technologies Inc
- Philippe Bastide, Head of Biosimilars, Mundipharma, Mundipharma International Limited
- Richard Peck, Vice President Regulatory Affairs, Lupin (Europe) Ltd
- Rod Ball, Owner and Director, Impact Medical Education
- Rodeina Challand, General Manager, Challand Biosimilar Consulting
- Ruediger Jankowsky, Managing Director, Cinfa Biotech
- Uwe Gudat, Head of Clinical Safety & Pharmacovigilance, Fresenius-Kabi
Please fill in your name and email to receive the conference agenda of this event.
Venue
Copthorne Tara Hotel
Scarsdale Pl, Kensington, W8 5SY
London, UK
Venue
Copthorne Tara HotelScarsdale Place, Kensington
London, United Kingdom
